Webinar: Life on Ibrance long-term

Ibrance (palbociclib) is a medicine used to treat advanced ER positive breast cancer. Some women find that it can keep their cancer at bay for two years or more. Managing side effects and dose changes can be important issues for these women and their clinicians. At this Breast Cancer Foundation-hosted webinar, visiting US oncologist Professor Adam Brufsky will share his insights on this important medicine. You can register to attend here. 

If you can’t attend, don’t worry – we will share the video of this webinar here on the BCAC website as soon as it becomes available.